Conatus Pharmaceuticals Current Ratio 2012-2019 | CNAT

Conatus Pharmaceuticals current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Conatus Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.03B $0.00B 6.13
2019-06-30 $0.04B $0.01B 2.97
2019-03-31 $0.04B $0.02B 2.40
2018-12-31 $0.05B $0.02B 2.56
2018-09-30 $0.06B $0.02B 2.40
2018-06-30 $0.07B $0.03B 2.35
2018-03-31 $0.07B $0.03B 2.41
2017-12-31 $0.08B $0.03B 2.82
2017-09-30 $0.09B $0.03B 2.69
2017-06-30 $0.10B $0.04B 2.77
2017-03-31 $0.08B $0.03B 2.39
2016-12-31 $0.08B $0.04B 2.03
2016-09-30 $0.03B $0.00B 8.12
2016-06-30 $0.03B $0.00B 9.61
2016-03-31 $0.03B $0.00B 11.16
2015-12-31 $0.04B $0.00B 9.66
2015-09-30 $0.04B $0.00B 12.17
2015-06-30 $0.05B $0.00B 13.28
2015-03-31 $0.03B $0.00B 10.09
2014-12-31 $0.04B $0.00B 9.07
2014-09-30 $0.04B $0.00B 9.63
2014-06-30 $0.05B $0.00B 14.60
2014-03-31 $0.00B 0.00
2013-12-31 $0.06B $0.00B 20.20
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.00B 5.75
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.012B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.637B 27.48
Medtronic (MDT) Ireland $150.042B 20.73
Stryker (SYK) United States $76.456B 25.71
Boston Scientific (BSX) United States $59.948B 28.30
Baxter (BAX) United States $42.085B 25.52
Essilor Luxottica (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.517B 19.15
Terumo (TRUMY) Japan $27.707B 34.58
Coloplast (CLPBY) Denmark $25.466B 39.30
Lonza Group Ag (LZAGY) Switzerland $25.140B 0.00
ResMed (RMD) United States $21.589B 39.83
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.307B 537.91
Bio-Rad Laboratories (BIO) United States $11.116B 53.36
DiaSorin S.p.A (DSRLF) Italy $7.580B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.111B 20.97
Perrigo (PRGO) Ireland $6.899B 12.86
Canopy Growth (CGC) Canada $6.407B 0.00
Haemonetics (HAE) United States $6.041B 40.82
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.822B 30.09
ICU Medical (ICUI) United States $3.799B 24.77
Neogen (NEOG) United States $3.543B 59.28
GW Pharmaceuticals (GWPH) United Kingdom $3.272B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.243B 0.00
Quidel (QDEL) United States $2.849B 27.04
Aurora Cannabis (ACB) Canada $2.702B 0.00
Agios Pharmaceuticals (AGIO) United States $2.371B 0.00
National Vision Holdings (EYE) United States $2.367B 53.43
Cardiovascular Systems (CSII) United States $1.555B 0.00
InMode (INMD) Israel $1.371B 0.00
Aphria (APHA) $1.175B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.161B 23.26
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.953B 0.00
TG Therapeutics (TGTX) United States $0.816B 0.00
Lantheus Holdings (LNTH) United States $0.793B 19.80
Eagle Pharmaceuticals (EGRX) United States $0.762B 29.17
Omeros (OMER) United States $0.758B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.44
Quanterix (QTRX) United States $0.689B 0.00
PetIQ (PETQ) United States $0.644B 15.72
Cerus (CERS) United States $0.587B 0.00
Surmodics (SRDX) United States $0.553B 57.44
HEXO (HEXO) $0.548B 0.00
OraSure Technologies (OSUR) United States $0.476B 28.56
MacroGenics (MGNX) United States $0.473B 0.00
Owens & Minor (OMI) United States $0.439B 16.23
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.61
Meridian Bioscience (VIVO) United States $0.389B 13.37
Zynex (ZYXI) United States $0.341B 38.52
BioLife Solutions (BLFS) United States $0.332B 135.17
Bovie Medical (APYX) United States $0.271B 0.00
United Health Products (UEEC) United States $0.263B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.223B 0.00
Liberty Health Sciences (LHSIF) Canada $0.187B 0.00
Repro-Med Systems (KRMD) United States $0.187B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
MTech Acquisition (KERN) United States $0.128B 0.00
Fonar (FONR) United States $0.127B 8.92
Cytosorbents (CTSO) United States $0.122B 0.00
United-Guardian (UG) United States $0.092B 23.27
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00